Download presentation
Presentation is loading. Please wait.
Published byCameron Hodges Modified over 6 years ago
1
Dr. Syed Waleem Pasha Assistant Professor Yenepoya Medical College
COMPARISON OF SERUM PARAOXONASE LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME AND NORMAL SUBJECTS: CASE CONTROL STUDY Dr. Syed Waleem Pasha Assistant Professor Yenepoya Medical College
2
Background Materials and methods Results Conclusion
3
Background Atherosclerosis Role of HDL Risk factors
6
Risk factors conventional newer hs-CRP Markers of inflammation
Smoking Hypertension Elevated LDL Low HDL Insulin resistance and diabetes Obesity Mental stress and depression hs-CRP Markers of inflammation Homocysteine Fibrinogen and D-dimer Lipoprotein (a) Paraoxonase 1
7
Paraoxonase 1 (PON 1) Synthesized in liver Transported along HDL
Antioxidant function – prevents LDL oxidation Activity exclusively associated with HDL
8
Materials and Methods 60 patients with Acute Coronary Syndrome (ACS)
30 matched controls Serum paraoxonase (PON) levels, blood sugar, lipid profile History of smoking and alcohol intake History of diabetes and hypertension
9
Paraoxonase assay: Lipid profile: UV spectrophotometer
Enzymatic activity Reference range: 53 – 186 kU/L Lipid profile: Fasting Total cholesterol, High density lipoprotein and trigycerides – enzymatic method Low density lipoprotein – friedwald’s formula
10
Inclusion criteria: Exclusion criteria: Age > 18 yrs
Cases: patients diagnosed as acute coronary syndrome Controls: patients with ACS (history and investigations) Exclusion criteria: Renal failure Hepatic parenchymal disease Prior IHD, stroke, peripheral vascular disease in last three months Anti-lipid treatment for more than three months
11
Analysis: SPSS (statistical package for the social sciences) version 18 Department of statistics, Manipal university
12
Results
13
Age distribution
14
Age distribution AGE (YRS) CASES CONTROLS N PON 1 31-40 6 54.67 7
93.86 41-50 9 49.67 5 71.6 51-60 23 59.26 10 78.3 61-70 12 54.75 8 71.25 >70 50 TOTAL 60 30 P Value 0.307 0.098
15
Gender distribution GENDER CASES CONTROLS N PON 1 MALE 50 54.1 24
74.88 FEMALE 10 59 6 95.17 TOTAL 60 30 P Value 0.203 0.129
16
Smoking SMOKER CASES CONTROLS N PON 1 YES 36 53.06 14 82.21 NO 24
57.71 16 76.06 TOTAL 60 30 P value 0.266 0.865
17
Alcohol ALCOHOLIC CASES CONTROLS 23 N PON 1 YES 16 50.06 7 83.71 NO 44
56.68 77.48 TOTAL 60 30 P value 0.99 0.252
18
Diabetes DIABETIC CASES CONTROLS N PON 1 YES 36 52.89 9 78.78 NO 24
57.96 21 79 TOTAL 60 30 P value 0.81 0.435
19
Hypertension HYPERTENSIVE CASES CONTROLS N PON 1 YES 31 54.58 14 77.21
NO 29 55.28 16 80.44 TOTAL 60 30 P value 0.244 0.578
20
Total cholesterol TC (mg/dl) CASES CONTROLS N PON 1 <100 2 65 87.5
11 55.27 4 66.5 19 57.16 10 84.8 21 58.1 85.8 >250 7 35.86 55.25 TOTAL 60 30 P value 0.642 0.055
21
Triglycerides TG (mg/dl) CASES CONTROLS N PON 1 <80 11 60.73 7 90
81-160 30 57.1 12 83.8 16 48.12 10 66.55 >240 3 48 1 59 TOTAL 60 P value 0.247 0.702
22
HDL HDL (mg/dl) CASES CONTROLS N PON 1 <30 23 41.87 9 60.89 31-45
25 61.56 18 84.11 46-60 64.56 3 102 >60 71.33 TOTAL 60 30 P value 0.166 0.086
23
LDL LDL (mg/dl) CASES CONTROLS N PON 1 <100 11 56.82 5 78.4 101-125
20 58.15 8 74.38 12 61.5 7 92.14 9 50.44 83.4 >175 39.38 63.8 TOTAL 60 30 P value 0.238 0.074
24
Master CASES (N=60) CONTROLS (N=30) P value TC 193.4 197.23 0.663 TG
140.13 135.13 0.865 LDL 124.06 129.69 0.791 HDL 35.77 34.43 0.213 RBS 150.02 142.27 0.541 PON 1 54.92 78.93 0.034
25
Comparative study SINGH et al PRESENT STUDY CONTROLS (191) CASES (120)
PON 1 64.92 57.19 <0.05 54.92 78.93 0.034 TC 155.38 160.81 197.23 193.4 0.663 TG 150.4 131.45 135.13 140.13 0.791 LDL 84.77 97.59 <0.01 129.69 124.06 HDL 41.82 36.92 <0.001 34.43 35.77 0.213
26
Conclusion Cases had significantly lower serom PON 1 levels when compared to controls Low PON 1 levels can be an independent risk factor for IHD
27
Future Target for prophylaxis Marker of morbidity/ mortality
Risk stratification Other organ dysfunction (atherosclerosis)
28
Limitations: Small sample size Obesity not considered
Stable angina not considered Wide reference range
29
References Mackness MI, Bouiller A, Hennuyer M, Mackness B, Hall M, Tailleux A, et-al. Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits. Biochem Biophys Res Commun. 2000; 269: Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoproteins in LDL. FEBS Lett. 1991; 286: Watson AD, Berliner JA, Hama SY, La Du BN, Fault KF, Fogelman AM. Protective effect of HCL associated paraoxonase: inhibition of the biological activity of minimally oxidised LDL. J Clin Invest. 1995; 96:
30
Thank you
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.